Ruth Clifford

1.8k total citations
28 papers, 470 citations indexed

About

Ruth Clifford is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Ruth Clifford has authored 28 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 10 papers in Pathology and Forensic Medicine and 7 papers in Hematology. Recurrent topics in Ruth Clifford's work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Ruth Clifford is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Ruth Clifford collaborates with scholars based in United Kingdom, Ireland and Belgium. Ruth Clifford's co-authors include Anna Schuh, Adam Burns, Adele Timbs, Jenny C. Taylor, P. Armitage, Shirley Henderson, Jennifer Becq, David Bentley, Lisa Murray and Russell Grocock and has published in prestigious journals such as Blood, Clinical Cancer Research and The Journal of Infectious Diseases.

In The Last Decade

Ruth Clifford

24 papers receiving 462 citations

Peers

Ruth Clifford

GENET

PFM

IMMUN

Adam Burns United Kingdom

Adele Timbs United Kingdom

Christoffer Flensburg Australia

Nikos Papakonstantinou Greece

Nadine Kutsch Germany

Daphne R. Friedman United States

Gottfried von Keudell United States

Andreas Himmelmann Switzerland

Vundavalli V. Murty United States

Koorosh Korfi United Kingdom

Adam Burns United Kingdom

Ruth Clifford

250 ×0.9

GENET

187 ×0.8

PFM

148 ×1.0

100 ×0.9

IMMUN

105 ×1.0

Citations per year, relative to Ruth Clifford Ruth Clifford (= 1×) peers Adam Burns

Countries citing papers authored by Ruth Clifford

Since Specialization

Citations

This map shows the geographic impact of Ruth Clifford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Clifford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Clifford more than expected).

Fields of papers citing papers by Ruth Clifford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Clifford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Clifford. The network helps show where Ruth Clifford may publish in the future.

Co-authorship network of co-authors of Ruth Clifford

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Clifford. A scholar is included among the top collaborators of Ruth Clifford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Clifford. Ruth Clifford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ryan, Charlotte, Dervla Kelly, Rajnish K. Gupta, et al.. (2024). Lymphoma follow-up pathway: A 10-year study to guide practice. European Journal of Oncology Nursing. 74. 102757–102757.

Millar, Seán, Conan Donnelly, Paul M. Walsh, et al.. (2021). Examining the Usefulness of the Charlson Comorbidity Index to Predict Early Mortality in Patients with Acute Myeloid Leukaemia. Blood. 138(Supplement 1). 1218–1218.

Catherwood, Mark, David González, David Donaldson, et al.. (2019). Relevance of TP53 for CLL diagnostics. Journal of Clinical Pathology. 72(5). 343–346. 11 indexed citations

Buchanan, James, Sarah Wordsworth, Ruth Clifford, et al.. (2017). Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis. PharmacoEconomics. 35(8). 845–858. 10 indexed citations

Pandzic, Tatjana, Jimmy Larsson, Liqun He, et al.. (2016). Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 22(24). 6217–6227. 14 indexed citations

Stamatopoulos, Basile, Adele Timbs, Tom Smith, et al.. (2016). Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia. Leukemia. 31(4). 837–845. 37 indexed citations

Stamatopoulos, Basile, Pavlos Antoniou, Dimitris Vavoulis, et al.. (2016). Characterization of Recurrent Mutations in Patient with a Richter Syndrome By Targeted Next Generation Sequencing. Blood. 128(22). 3200–3200. 2 indexed citations

Robbe, Pauline, Kate Ridout, Jennifer Becq, et al.. (2016). Identifying High-Risk CLL to Predict Early Relapse after FCR Based Treatment Using Whole Genome Sequencing: First Results from the Genomics England CLL Pilot. Blood. 128(22). 2022–2022. 1 indexed citations

Eyre, Toby A., Ruth Clifford, Adrian Bloor, et al.. (2015). SINGLE ARM NCRI FEASIBILITY PHASE II STUDY OF CHOP IN COMBINATION WITH OFATUMUMAB IN INDUCTION AND MAINTENANCE FOR PATIENTS WITH NEWLY DIAGNOSED RICHTER'S SYNDROME. Haematologica. 100. 109–109. 2 indexed citations

10.

Eyre, Toby A., Ruth Clifford, Corran Roberts, et al.. (2015). Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter’s syndrome. BMC Cancer. 15(1). 52–52. 8 indexed citations

11.

Hamblin, Angela, Adam Burns, Ruth Clifford, et al.. (2014). Development and Evaluation of the Clinical Utility of a Next Generation Sequencing (NGS) Tool for Myeloid Disorders. Blood. 124(21). 2373–2373. 1 indexed citations

12.

Mead, Adam J., Onima Chowdhury, C. Pecquet, et al.. (2013). Impact of isolated germline JAK2V617I mutation on human hematopoiesis. Blood. 121(20). 4156–4165. 35 indexed citations

13.

Mead, Janet E., Onima Chowdhury, Alexandra Dusa, et al.. (2012). GERMLINE ACTIVATING JAK2-MUTATION IN A FAMILY WITH HEREDITARY THROMBOCYTOSIS. Haematologica. 97. 146–147. 1 indexed citations

14.

Knight, Samantha J.L., Christopher Yau, Ruth Clifford, et al.. (2012). Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia. Leukemia. 26(7). 1564–1575. 45 indexed citations

15.

Clifford, Ruth & Anna Schuh. (2012). State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia. Clinical Medicine Insights Oncology. 6. 165–78. 2 indexed citations

16.

Medd, Patrick, Robert Danby, Ram Malladi, et al.. (2011). Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant. International Journal of Hematology. 94(3). 266–278. 2 indexed citations

17.

Mead, Adam J., Petter Woll, Ruth Clifford, et al.. (2011). Germline Activating JAK2 V617I Mutation in a Family with Hereditary Thrombocytosis. Blood. 118(21). 1738–1738. 1 indexed citations

18.

Clifford, Ruth, et al.. (2010). Increased Efficacy of Anaemia Treatment in Cancer. European Oncology & Haematology. 0(4). 8–8. 1 indexed citations

19.

Medd, Patrick, Simon Littlewood, Robert Danby, et al.. (2010). Paraproteinaemia after allo-SCT, association with alemtuzumab-based conditioning and CMV reactivation. Bone Marrow Transplantation. 46(7). 993–999. 4 indexed citations

20.

Armitage, P. & Ruth Clifford. (1978). Prognosis in Tetanus: Use of Data from Therapeutic Trials. The Journal of Infectious Diseases. 138(1). 1–8. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact